0000906344-05-000112.txt : 20120614 0000906344-05-000112.hdr.sgml : 20120614 20050412144639 ACCESSION NUMBER: 0000906344-05-000112 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050412 DATE AS OF CHANGE: 20050412 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDICALCV INC CENTRAL INDEX KEY: 0001144284 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 411717208 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-62263 FILM NUMBER: 05746046 BUSINESS ADDRESS: STREET 1: 9725 SOUTH ROBERT TRAIL CITY: INVER GROVE HEIGHTS STATE: MN ZIP: 55077 BUSINESS PHONE: 6514523000 MAIL ADDRESS: STREET 1: 9725 SOUTH ROBERT TRAIL CITY: INVER GROVE HEIGHTS STATE: MN ZIP: 55077 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MEDCAP PARTNERS LP CENTRAL INDEX KEY: 0001176482 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 500 THIRD STREET STREET 2: SUITE 535 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-495-1010 MAIL ADDRESS: STREET 1: 500 THIRD STREET STREET 2: SUITE 535 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 SC 13G 1 med13g.txt 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 MedicalCV, Inc. --------------- (Name of Issuer) Common Stock ------------ (Title of Class of Securities) 584639 10 8 ----------- (CUSIP Number) April 1, 2005 ------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 584639 10 8 SCHEDULE 13G Page 2 of 12 1 Name of Reporting Person MEDCAP MANAGEMENT & RESEARCH LLC IRS Identification No. of Above Person 94-3411543 2 Check the Appropriate Box if a member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization DELAWARE NUMBER OF 5 Sole Voting Power 0 SHARES BENEFICIALLY 6 Shared Voting Power 1,192,876 OWNED BY EACH REPORTING 7 Sole Dispositive Power 0 PERSON WITH 8 Shared Dispositive Power 1,192,876 9 Aggregate Amount Beneficially Owned by Each 1,192,876 Reporting Person 10 Check Box if the Aggregate Amount in Row (9) Excludes [ ] Certain Shares 11 Percent of Class Represented by Amount in Row 9 9.999% 12 Type of Reporting Person IA CUSIP No. 584639 10 8 SCHEDULE 13G Page 3 of 12 1 Name of Reporting Person MEDCAP PARTNERS L.P. IRS Identification No. of Above Person 94-3412423 2 Check the Appropriate Box if a member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization DELAWARE NUMBER OF 5 Sole Voting Power 0 SHARES BENEFICIALLY 6 Shared Voting Power 1,192,876 OWNED BY EACH REPORTING 7 Sole Dispositive Power 0 PERSON WITH 8 Shared Dispositive Power 1,192,876 9 Aggregate Amount Beneficially Owned by Each 1,192,876 Reporting Person 10 Check Box if the Aggregate Amount in Row (9) Excludes [ ] Certain Shares 11 Percent of Class Represented by Amount in Row 9 9.999% 12 Type of Reporting Person PN CUSIP No. 584639 10 8 SCHEDULE 13G Page 4 of 12 1 Name of Reporting Person MEDCAP MASTER FUND L.P. IRS Identification No. of Above Person 98-0437526 2 Check the Appropriate Box if a member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization CAYMAN ISLANDS NUMBER OF 5 Sole Voting Power 0 SHARES BENEFICIALLY 6 Shared Voting Power 1,192,876 OWNED BY EACH REPORTING 7 Sole Dispositive Power 0 PERSON WITH 8 Shared Dispositive Power 1,192,876 9 Aggregate Amount Beneficially Owned by Each 1,192,876 Reporting Person 10 Check Box if the Aggregate Amount in Row (9) Excludes [ ] Certain Shares 11 Percent of Class Represented by Amount in Row 9 9.999% 12 Type of Reporting Person PN CUSIP No. 584639 10 8 SCHEDULE 13G Page 5 of 12 1 Name of Reporting Person C. FRED TONEY IRS Identification No. of Above Person 2 Check the Appropriate Box if a member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization UNITED STATES NUMBER OF 5 Sole Voting Power 0 SHARES BENEFICIALLY 6 Shared Voting Power 1,192,876 OWNED BY EACH REPORTING 7 Sole Dispositive Power 0 PERSON WITH 8 Shared Dispositive Power 1,192,876 9 Aggregate Amount Beneficially Owned by Each 1,192,876 Reporting Person 10 Check Box if the Aggregate Amount in Row (9) Excludes [ ] Certain Shares 11 Percent of Class Represented by Amount in Row 9 9.999% 12 Type of Reporting Person IN/HC CUSIP No. 584639 10 8 SCHEDULE 13G Page 6 of 12 Item 1(a). Name of Issuer: MedicalCV, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 9725 South Robert Trail, Inver Grove Heights, MN 55077 Item 2(a). Names of Persons Filing: MedCap Management & Research LLC ("MMR") MedCap Partners L.P. ("MedCap Partners") MedCap Master Fund L.P. ("MedCap Master Fund") C. Fred Toney Item 2(b). Address of Principal Business Office or, if none, Residence: The principal business office address of MMR, MedCap Partners and Toney is 500 Third Street, Suite 535, San Francisco, CA 94107. The principal business address of MedCap Master Fund is c/o ATC Trustees (Cayman) Limited, Cayside, 2nd Floor, Harbour Drive, George Town, Grand Cayman, Cayman Islands. Item 2(c). Citizenship: Reference is made to item 4 of pages two (2), three (3), four (4) and five (5) of this Schedule 13G, which Items are incorporated by reference herein. Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 584639 10 8 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); CUSIP No. 584639 10 8 SCHEDULE 13G Page 7 of 12 (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) [x] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [x] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4. Ownership. MedCap Partners is the record owner of 2,000 shares of the Issuer's 5% Series A Convertible Preferred Stock and holds warrants to purchase 3,000,000 shares of the Issuer's Common Stock. MedCap Master Fund owns 1,500 shares of the Issuer's 5% Series A Convertible Preferred Stock and holds warrants to purchase 2,250,000 shares of the Issuer's Common Stock. Subject to the Conversion Restrictions (defined below), as of the date hereof, each share of the Issuer's 5% Series A Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's Common Stock. The conversion of the Issuer's 5% Series A Convertible Preferred Stock and the exercise of the warrants are subject to restrictions (the "Ownership Limitations") that prohibit conversion or exercise to the extent that the number of shares of the Issuer's Common stock beneficially owned by MedCap Partners or MedCap Master Fund and their affiliates and other persons whose beneficial ownership is aggregated with them would exceed 9.999% of the total number of issued and outstanding shares of the Issuer's Common Stock, including for such purpose the shares of Common Stock issuable upon such conversion and/or exercise. Based on 10,737,083 shares of Common Stock of the Issuer outstanding as of March 15, 2005, as indicated in the Issuer's Quarterly Report on Form 10-QSB for the quarterly period ended January 31, 2005, the Reporting Persons have the right to acquire up to 1,192,876 shares of the Issuer's Common Stock through the exercise of warrants and/or the conversion of shares of the Issuer's 5% Series A Convertible Preferred Stock. The securities to which this Schedule 13G relates consist of CUSIP No. 584639 10 8 SCHEDULE 13G Page 8 of 12 2,000,0000 shares of Series A Convertible Preferred Stock, which are currently convertible into 2,000,000 shares of common stock and which vote along with the common stock on an as-converted basis. MMR as general partner and investment manager of MedCap Partners and MedCap Master Fund and C. Fred Toney as managing member of MMR may be deemed to beneficially own the shares owned by MedCap Partners and MedCap Master Fund in that they may be deemed to have the power to direct the voting or disposition of the shares. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission that either MMR or Mr. Toney is, for any purpose, the beneficial owner of any such securities to which this Schedule relates, and MMR and Mr. Toney disclaim beneficial ownership as to the 2,000,000 preferred shares and the underlying common shares, except to the extent of their respective pecuniary interests therein. Under the definition of "beneficial ownership" in Rule 13d-3 under the Securities Exchange Act of 1934, it is also possible that the individual general partners, directors, executive officers, and members of the foregoing entities might be deemed the "beneficial owners" of some or all of the securities to which this Schedule relates in that they might be deemed to share the power to direct the voting or disposition of such securities. Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of such individuals is, for any purpose, the beneficial owner of any of the securities to which this Schedule relates, and such beneficial ownership is expressly disclaimed. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 584639 10 8 SCHEDULE 13G Page 9 of 12 Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: April 11, 2005 MEDCAP MANAGEMENT & RESEARCH LLC By:/s/ C. Fred Toney ---------------------------------- C. Fred Toney, its Managing Member C. FRED TONEY /s/ C. Fred Toney ------------------------------------- C. Fred Toney By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. CUSIP No. 584639 10 8 SCHEDULE 13G Page 10 of 12 Dated: April 11, 2005 MEDCAP PARTNERS L.P. By: MedCap Management & Research LLC, its General Partner By:/s/ C. Fred Toney ---------------------------------- C. Fred Toney, its Managing Member MEDCAP MASTER FUND L.P. By: MedCap Management & Research LLC, its General Partner By:/s/ C. Fred Toney ---------------------------------- C. Fred Toney, its Managing Member CUSIP No. 584639 10 8 SCHEDULE 13G Page 11 of 12 EXHIBIT INDEX Exhibit A Joint Filing Undertaking Page 11 CUSIP No. 584639 10 8 SCHEDULE 13G Page 12 of 12 EXHIBIT A JOINT FILING UNDERTAKING The undersigned, being authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule, as it may be amended, jointly on behalf of each of such parties. Dated: April 11, 2005 MEDCAP MANAGEMENT & RESEARCH LLC By:/s/ C. Fred Toney ---------------------------------- C. Fred Toney, its Managing Member MEDCAP PARTNERS L.P. By: MedCap Management & Research LLC, its General Partner By:/s/ C. Fred Toney ---------------------------------- C. Fred Toney, its Managing Member MEDCAP MASTER FUND, L.P. By: MedCap Management & Research LLC, its General Partner By:/s/ C. Fred Toney ---------------------------------- C. Fred Toney, its Managing Member C. FRED TONEY /s/ C. Fred Toney ------------------------------------- C. Fred Toney